asthma	is a	chronic inflammatory airway disease
asthma	characterized by	airway hyperresponsiveness
asthma	characterized by	reversible airflow limitation
asthma	presents with	wheeze
asthma	presents with	cough
asthma	presents with	dyspnea
asthma	presents with	chest tightness
asthma	involves	airway inflammation
airway inflammation	contributes to	asthma symptoms
airway remodeling	occurs in	asthma
airway remodeling	leads to	fixed obstruction
asthma	is associated with	atopy
asthma	is associated with	allergic rhinitis
asthma	is associated with	eczema
asthma	has	eosinophilic inflammation
eosinophils	elevated in	asthma
eosinophilic inflammation	characterizes	eosinophilic asthma
nasal polyps	coexist with	asthma
rhinitis	coexist with	asthma
sinusitis	coexist with	asthma
obesity	increases risk of	asthma
smoking exposure	increases risk of	asthma
air pollution	increases risk of	asthma
viral infection	triggers	asthma exacerbation
exercise	triggers	asthma symptoms
cold air	triggers	asthma symptoms
aspirin sensitivity	associated with	asthma
airway hyperresponsiveness	core feature of	asthma
family history	increases risk of	asthma
genetic predisposition	contributes to	asthma
inhaled corticosteroids	reduce	asthma symptoms
inhaled corticosteroids	reduce	exacerbations
short-acting beta-agonist	provides	bronchodilation
short-acting beta-agonist	relief of	wheeze
long-acting beta-agonist	added to	inhaled corticosteroids
inhaled corticosteroids and long-acting beta-agonist	combination therapy	asthma
oral corticosteroids	used for	severe asthma
systemic corticosteroids	used for	acute severe asthma
leukotriene receptor antagonists	used for	asthma
montelukast	is a	leukotriene receptor antagonist
omalizumab	is used for	allergic asthma
mepolizumab	is used for	eosinophilic asthma
benralizumab	is used for	eosinophilic asthma
dupilumab	is used for	type 2 asthma
airway smooth muscle	hypertrophy	asthma
eosinophils	elevated in	eosinophilic asthma
type 2 asthma	defined by	eosinophilic inflammation
feno	indicates	airway inflammation
feno	used for	asthma monitoring
spirometry	used for	asthma diagnosis
fev1	decreases in	asthma attack
airflow obstruction	reversible with	bronchodilators
bronchodilators	provide	symptomatic relief
nebulized therapy	used for	acute asthma attack
inhaler technique	affects	asthma control
adherence	affects	asthma control
asthma control	assessed by	act score
act score	reflects	asthma control
peak expiratory flow	monitors	asthma control
asthma control	correlated with	quality of life
allergic rhinitis	common comorbidity in	asthma
asthma	increases risk of	emergency department visits
asthma	increases risk of	hospitalizations
asthma	increases cost of	healthcare
asthma	causes	morbidity in children
asthma persists into	adulthood
pediatric asthma	is diagnosed with	spirometry
pediatric asthma	often presents with	cough
pediatric asthma	commonly coexists with	allergic rhinitis
asthma phenotype	includes	allergic asthma
asthma phenotype	includes	non-eosinophilic asthma
non-eosinophilic asthma	characterized by	neutrophilic inflammation
neutrophils	present in	non-eosinophilic asthma
inhaled devices	enable	asthma treatment
aerosol therapy	delivers	asthma medications
breathing exercises	adjunct to	asthma management
physical activity	recommended for	asthma management
influenza vaccination	reduces	asthma exacerbations
seasonal allergies	worsen	asthma symptoms
airway remodeling	contributes to	asthma severity
obesity	worsens	asthma control
sleep disturbance	associated with	asthma nocturnal symptoms
nocturnal symptoms	indicate	poor asthma control
childhood asthma	persists into	adulthood
bronchial challenge test	measures	airway hyperresponsiveness
feno	used for	airway inflammation monitoring
mold exposure	triggers	asthma symptoms
occupational exposure	leads to	occupational asthma
sulfite sensitivity	triggers	asthma symptoms
eosinophilic phenotype	exists in	asthma
neutrophilic phenotype	exists in	asthma
biologic therapy	reserved for	severe asthma
dupilumab	targets	il-4 receptor alpha
omalizumab	targets	igE
ige	mediates	allergic asthma
ige	bound by	omalizumab
mepolizumab	reduces	blood eosinophil count
blood eosinophil count	correlates with	asthma control
asthma	requires	regular follow-up
asthma management	aims for	symptom control
